Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

686.23
Delayed Data
As of May 24
 +4.11 / +0.60%
Today’s Change
492.13
Today|||52-Week Range
747.42
+8.66%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 707.50, with a high estimate of 790.00 and a low estimate of 565.00. The median estimate represents a +3.10% increase from the last price of 686.23.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$10.17
Sales
$2.8B
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.49%
 
 
 
 
 
 
Growthannually -41.05%
 
 
 
 
 
 

Sales

Growthquarterly -5.05%
 
 
 
 
 
 
Growthannually -26.09%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.